Status:
UNKNOWN
Assessment Of Liver and Spleen Fibrosis in Patients With Gaucher Disease Using Fibroscan
Lead Sponsor:
Rambam Health Care Campus
Conditions:
Fibrosis
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
The investigated cohort will examine liver and spleen fibrosis in patients with Gaucher disease divided into two groups, naive GD patients and GD patients treated with ERT. As liver biopsy in these pa...
Detailed Description
The investigated cohort will include 4 groups of patients 20 probands in each group including: 1) Naïve GD patients 2) GD treated with ERT 3) Healthy control 4) Patients with NonAlcoholic Steatohepati...
Eligibility Criteria
Inclusion
- Diagnosis of Gaucher in treatment and without treatment.
- Healthy control.
- Patients with Non Alcoholic Steatohepatitis( NASH) which are followed at hepatology unit.
Exclusion
- • Active liver disease ,cirrhosis patients.
Key Trial Info
Start Date :
August 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2016
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT01898325
Start Date
August 1 2013
End Date
December 1 2016
Last Update
July 12 2013
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.